Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases

Anti-vascular endothelial growth factors (anti-VEGF) have become the most common treatment modality for many retinal diseases. These include neovascular age-related macular degeneration (n-AMD), proliferative diabetic retinopathy (PDR) and retinal vein occlusions (RVO). However, these drugs are admi...

Descripción completa

Detalles Bibliográficos
Autores principales: Seah, Ivan, Zhao, Xinxin, Lin, Qianyu, Liu, Zengping, Su, Steven Zheng Zhe, Yuen, Yew Sen, Hunziker, Walter, Lingam, Gopal, Loh, Xian Jun, Su, Xinyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376230/
https://www.ncbi.nlm.nih.gov/pubmed/32001821
http://dx.doi.org/10.1038/s41433-020-0770-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376230/
https://www.ncbi.nlm.nih.gov/pubmed/32001821
http://dx.doi.org/10.1038/s41433-020-0770-y

Ejemplares similares